Portal de Periódicos da CAPES

Tricuspid valve disease and cardiac implantable electronic devices

2023; Oxford University Press; Volume: 45; Issue: 5 Linguagem: Inglês

10.1093/eurheartj/ehad783

1522-9645

Martin Andreas, Haran Burri, Fabien Praz, Osama Soliman, Luigi P. Badano, Manuel Barreiro‐Pérez, João L. Cavalcante, Tom De Potter, Torsten Doenst, Kai Friedrichs, Jörg Hausleiter, Nicole Karam, Susheel Kodali, Azeem Latib, Éloi Marijon, Suneet Mittal, Georg Nickenig, Christopher A. Rinaldi, Piotr Nikodem Rudziński, Marco Russo, Christoph Starck, Ralph Stephan von Bardeleben, Nina Wunderlich, José Luis Zamorano, Rebecca T. Hahn, Francesco Maisano, Christophe Leclercq,

Cardiac Structural Anomalies and Repair

The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.